MedTrace Logo

IVN-CAT-001A Performance of CAST With Different Allergens in Patients With Cat Dander Allergy

NCT00620880 · Status: COMPLETED · Type: OBSERVATIONAL

Last updated 2008-11-20

No results posted yet for this study

Summary

Primary objective of the trial:

To determine at which concentration the fusion protein MAT Fel d1 degranulates basophils of cat dander allergic patients, in comparison to a cat dander extract and to Fel d1 alone

Conditions

  • Allergy to Cats

Interventions

BEHAVIORAL

Blood sample

Sponsors & Collaborators

  • ImVision AG

    collaborator UNKNOWN

  • University of Zurich

    lead OTHER

Principal Investigators

  • 01 Studienregister MasterAdmins · UniversitaetsSpital Zuerich

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-09-30
Completion
2006-09-30

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00620880 on ClinicalTrials.gov